New PET Tracer Detects More Metastases in Cancer Patients

A new product that homes in on fibroblast activation protein may be a "paradigm shift" to better identification and targeting of many cancers, say experts.
Medscape Medical News

source https://www.medscape.com/viewarticle/968064?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost